Carcinoma of Ureter
📧 Sign up to get email alerts when something new happens for Carcinoma of Ureter.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma [Phase 2]
Phase 2 trial evaluating ramucirumab or IMC-18F1 with docetaxel vs docetaxel alone as second-line therapy for urinary tract carcinomas, comp…